You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Merck
Moodys
Colorcon
McKinsey

Last Updated: September 21, 2020

DrugPatentWatch Database Preview

PEMOLINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for PEMOLINE
Drug patent expirations by year for PEMOLINE
Recent Clinical Trials for PEMOLINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Medical University of ViennaPhase 2
California Pacific Medical Center Research InstitutePhase 2
Sheba Medical CenterN/A

See all PEMOLINE clinical trials

Medical Subject Heading (MeSH) Categories for PEMOLINE

US Patents and Regulatory Information for PEMOLINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth PEMOLINE pemoline TABLET, CHEWABLE;ORAL 075678-001 Jul 26, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs PEMOLINE pemoline TABLET;ORAL 075287-001 Jun 13, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Fosun Pharma PEMOLINE pemoline TABLET;ORAL 075286-002 Jun 30, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
Actavis Elizabeth PEMOLINE pemoline TABLET;ORAL 075595-002 Feb 28, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Pharms PEMOLINE pemoline TABLET;ORAL 075030-003 Feb 22, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs PEMOLINE pemoline TABLET;ORAL 075287-003 Sep 18, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Fosun Pharma PEMOLINE pemoline TABLET;ORAL 075286-003 Jun 30, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Express Scripts
Boehringer Ingelheim
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.